TickerFacts.

NovaBridge Biosciences (NBP): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Operating Cash Flow or Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-1.32B CNY
Year ended 2023-12-31
425.55M CNY2017-12-31: -272.48M CNY2018-12-31: -295.11M CNY2019-12-31: -880.22M CNY2020-12-31: 425.55M CNY2021-12-31: -1.00B CNY2022-12-31: -1.15B CNY2023-12-31: -1.32B CNY-1.32B CNY
2017-12-31 Free Cash Flow (CNY) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-1.32B CNYn/m2024-04-30, From 2023-01-01
2022-12-31-1.15B CNYn/m2024-04-30, From 2022-01-01
2021-12-31-1.00B CNYn/m2024-04-30, From 2021-01-01
2020-12-31425.55M CNYn/m2023-05-01, From 2020-01-01
2019-12-31-880.22M CNYn/m2022-04-29, From 2019-01-01
2018-12-31-295.11M CNYn/m2021-04-28, From 2018-01-01
2017-12-31-272.48M CNYn/a2020-04-29, From 2017-01-01